Stock Scorecard
Stock Summary for SI-BONE Inc (SIBN) - $15.27 as of 4/24/2024 12:23:28 PM EST
Total Score
12 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SIBN
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SIBN
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SIBN
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for SIBN
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for SIBN
Financial Details for SIBN
Company Overview |
|
---|---|
Ticker | SIBN |
Company Name | SI-BONE Inc |
Country | USA |
Description | SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and internationally. The company is headquartered in Santa Clara, California. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/6/2024 |
Stock Price History |
|
Last Day Price | 15.27 |
Last Day Price Updated | 4/24/2024 12:23:28 PM EST |
Last Day Volume | 312,422 |
Average Daily Volume | 419,923 |
52-Week High | 29.51 |
52-Week Low | 14.84 |
Last Price to 52 Week Low | 2.90% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 47.46 |
Sector PE | 60.54 |
5-Year Average PE | -11.75 |
Free Cash Flow Ratio | 4.02 |
Industry Free Cash Flow Ratio | 61.03 |
Sector Free Cash Flow Ratio | 30.19 |
Current Ratio Most Recent Quarter | 9.01 |
Total Cash Per Share | 3.80 |
Book Value Per Share Most Recent Quarter | 4.16 |
Price to Book Ratio | 3.63 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 4.43 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 41,064,500 |
Market Capitalization | 627,054,915 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 29.25% |
Reported EPS 12 Trailing Months | -1.13 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -1.14 |
Net Income Twelve Trailing Months | -43,336,000 |
Net Income Past Year | -43,336,000 |
Net Income Prior Year | -61,256,000 |
Quarterly Revenue Growth YOY | 21.60% |
5-Year Revenue Growth | 19.35% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 156,079,000 |
Total Cash Past Year | 156,079,000 |
Total Cash Prior Year | 84,575,000 |
Net Cash Position Most Recent Quarter | 120,014,000 |
Net Cash Position Past Year | 120,014,000 |
Long Term Debt Past Year | 36,065,000 |
Long Term Debt Prior Year | 35,171,000 |
Total Debt Most Recent Quarter | 36,065,000 |
Equity to Debt Ratio Past Year | 0.82 |
Equity to Debt Ratio Most Recent Quarter | 0.82 |
Total Stockholder Equity Past Year | 169,375,000 |
Total Stockholder Equity Prior Year | 98,302,000 |
Total Stockholder Equity Most Recent Quarter | 169,375,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.53 |
MACD Signal | -0.60 |
20-Day Bollinger Lower Band | 14.06 |
20-Day Bollinger Middle Band | 18.45 |
20-Day Bollinger Upper Band | 22.84 |
Beta | 1.22 |
RSI | 41.32 |
50-Day SMA | 20.92 |
200-Day SMA | 21.50 |
System |
|
Modified | 4/23/2024 11:19:39 AM EST |